Exosomes are a novel form of biotherapeutics, but their production and purification are similar to conventional biologics manufacturing, both in terms of upstream and downstream development.
Cell Line Development
We have established well characterised, regulatory compliant proprietary cell lines for the manufacture of our engineered exosome therapeutics and have established leading capabilities for cell line development.
Manufacturing and Scale Up
Our team of experienced development scientists and engineers have developed a GMP compliant, scalable, commercially viable manufacturing platform which forms part of the DeliverEX® platform and which assures the quality, safety and efficacy of our exosome therapeutics.
- Suspension, chemically defined growth media and feeds
- Efficient purification
- Proprietary GRAS formulations to enhance product stability
We have developed a suite of state-of-the-art exosome specific characterisation methodologies which underpin product understanding and delivery of safe and efficacious exosome therapeutics.